Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Ketamine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/16/2018
»Therapeutic Categories: Anesthesia
Eugia US LLC (Revised 04/22/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 55150-438-10) | Available | Intermittent availability expected | Demand increase for the drug |
| Injection, 50 mg/1 mL (NDC 55150-439-10) | Unavailable | Intermittent availability expected | Demand increase for the drug |
| Injection, 100 mg/1 mL (NDC 55150-440-10) | Unavailable | Intermittent availability expected | Demand increase for the drug |
Fresenius Kabi USA, LLC (New 04/17/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 65219-184-20) | Available | Check wholesaler inventory | |
| Injection, 50 mg/1 mL (NDC 65219-188-10) | Available | Check wholesaler inventory |
Gland Pharma Limited (Revised 03/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketamine Hydrochloride, Injection, 10 mg/1 mL (NDC 25021-682-20) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 | |
| Ketamine Hydrochloride, Injection, 50 mg/1 mL (NDC 25021-683-10) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 | |
| Ketamine Hydrochloride, Injection, 100 mg/1 mL (NDC 25021-684-05) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 |
Hikma Pharmaceuticals USA, Inc. (Reverified 03/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketamine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0143-9508-10) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Ketamine HCl Injection, USP, Injection, 100 mg/1 mL (NDC 0143-9509-10) | Unavailable | Additional lots will be available in the March - April 2024 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Revised 04/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 100 mg/1 mL (NDC 0409-2051-05) | Limited Availability | Estimated Recovery: September 2024; Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| Ketamine Hydrochloride, Injection, 50 mg/1 mL (NDC 0409-2053-10) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025; Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
Par Pharmaceutical, Inc. (Reverified 04/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketalar, Injection, 10 mg/1 mL (NDC 42023-113-10) | Unavailable | Recovery: TBD | Shortage of an active ingredient |
| Ketalar, Injection, 100 mg/1 mL (NDC 42023-115-10) | Unavailable | Recovery: TBD | Shortage of an active ingredient |
| Ketalar, Injection, 50 mg/1 mL (NDC 42023-114-10) | Unavailable | Recovery: TBD | Shortage of an active ingredient |